Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04965675 · ClinicalTrials.gov registry record · Phase 3
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
A Phase 3 study of Chronic Migraine in Children, sponsored by H. Lundbeck A/S.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 285
- Enrollment target
- 20
- Study locations
NCT04965675 is a Phase 3 study of Chronic Migraine in Children that is actively recruiting participants, run by H. Lundbeck A/S. The registered enrollment target is 285 participants. The trial reports 20 study locations across 13 states.
The verdict
NCT04965675, a Phase 3 study of Chronic Migraine in Children, is actively recruiting participants, sponsored by H. Lundbeck A/S.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 285 participants
- Enrollment target
- 20
- Study locations
Study Summary
To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Eptinezumab
Study Locations (20)
Florida
- NW FL Clinical Research Group, LLC - Gulf Breeze
- AGA Clinical Trials - Hialeah
- Axcess Medical Research - Loxahatchee Groves
- University of South Florida - Tampa
Michigan
- Michigan Head Pain and Neurological Institute - Ann Arbor
- Michigan State University - Department of Neurology - East Lansing
- Corewell Health Butterworth Hospital - Grand Rapids
Connecticut
- Yale-New Haven Children's Hospital - PIN - New Haven
- Ki Health Partners LLC DBA New England Institute for Clinical Research - Stamford
New York
- Dent Neurosciences Research Center Incorporated - Amherst
- North Suffolk Neurology-Commack - Commack
District of Columbia
- Children's National Medical Center - Washington D.C.
Georgia
- Clinical Integrative Research Center of Atlanta - Atlanta
Kentucky
- University of Kentucky HealthCare (UKHC) Kentucky Clinic - Lexington
Maryland
- University of Maryland - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2021-06-30 |
| Est. Completion | 2026-10-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04965675
The ClinicalTrials.gov registry entry for NCT04965675 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lundbeck A/S, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Migraine in Children appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04965675 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Florida, Michigan, Connecticut.
Frequently Asked Questions
What is clinical trial NCT04965675 about?
NCT04965675 is a clinical study titled "A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine". To find out if eptinezumab is better than placebo (normal saline solution) in lowering the number of days with migraine in young people ages 12 to 17 with chronic migraine.
What is the current status of trial NCT04965675?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 285 participants. The study started on 2021-06-30. Estimated completion is 2026-10-31.
What conditions does trial NCT04965675 study?
This clinical trial studies the following conditions: Chronic Migraine in Children.
What interventions are being tested in trial NCT04965675?
The interventions under investigation include: Placebo (DRUG), Eptinezumab (DRUG).
Who is sponsoring clinical trial NCT04965675?
This trial is sponsored by H. Lundbeck A/S, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04965675 being conducted?
This trial has 20 study locations across Connecticut, District of Columbia, Florida, Georgia, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.